128 related articles for article (PubMed ID: 22925410)
1. Opioid substitution therapy clients' preferences for targeted versus general primary health-care outlets.
Islam MM; Topp L; Conigrave KM; Day CA
Drug Alcohol Rev; 2013 Mar; 32(2):211-4. PubMed ID: 22925410
[TBL] [Abstract][Full Text] [Related]
2. The politics of place(ment): problematising the provision of hepatitis C treatment within opiate substitution clinics.
Rance J; Newland J; Hopwood M; Treloar C
Soc Sci Med; 2012 Jan; 74(2):245-53. PubMed ID: 22133583
[TBL] [Abstract][Full Text] [Related]
3. How to build trustworthy hepatitis C services in an opioid treatment clinic? A qualitative study of clients and health workers in a co-located setting.
Treloar C; Rance J;
Int J Drug Policy; 2014 Sep; 25(5):865-70. PubMed ID: 24559604
[TBL] [Abstract][Full Text] [Related]
4. Client and staff experiences of a co-located service for hepatitis C care in opioid substitution treatment settings in New South Wales, Australia.
Treloar C; Rance J; Grebely J; Dore GJ
Drug Alcohol Depend; 2013 Dec; 133(2):529-34. PubMed ID: 23932843
[TBL] [Abstract][Full Text] [Related]
5. Uptake and delivery of hepatitis C treatment in opiate substitution treatment: perceptions of clients and health professionals.
Treloar C; Newland J; Rance J; Hopwood M
J Viral Hepat; 2010 Dec; 17(12):839-44. PubMed ID: 20070504
[TBL] [Abstract][Full Text] [Related]
6. A qualitative study of reasons for seeking and ceasing opioid substitution treatment in prisons in New South Wales, Australia.
Larney S; Zador D; Sindicich N; Dolan K
Drug Alcohol Rev; 2017 May; 36(3):305-310. PubMed ID: 27325289
[TBL] [Abstract][Full Text] [Related]
7. General health of opioid substitution therapy clients.
Islam MM; Taylor A; Smyth C; Day CA
Intern Med J; 2013 Dec; 43(12):1335-8. PubMed ID: 24330364
[TBL] [Abstract][Full Text] [Related]
8. Self-perceived problem with alcohol use among opioid substitution treatment clients.
Islam MM; Day CA; Conigrave KM; Topp L
Addict Behav; 2013 Apr; 38(4):2018-21. PubMed ID: 23384455
[TBL] [Abstract][Full Text] [Related]
9. Are primary health care centres that target injecting drug users attracting and serving the clients they are designed for? A case study from Sydney, Australia.
Islam MM; Topp L; Conigrave KM; White A; Haber PS; Day CA
Int J Drug Policy; 2013 Jul; 24(4):326-32. PubMed ID: 22818978
[TBL] [Abstract][Full Text] [Related]
10. Clients' perceptions of opioid substitution treatment: an input to improving the quality of treatment.
Deering D; Horn J; Frampton CM
Int J Ment Health Nurs; 2012 Aug; 21(4):330-9. PubMed ID: 22564199
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of two community-controlled peer support services for assessment and treatment of hepatitis C virus infection in opioid substitution treatment clinics: The ETHOS study, Australia.
Treloar C; Rance J; Bath N; Everingham H; Micallef M; Day C; Hazelwood S; Grebely J; Dore GJ
Int J Drug Policy; 2015 Oct; 26(10):992-8. PubMed ID: 25697089
[TBL] [Abstract][Full Text] [Related]
12. Knowledge and barriers associated with assessment and treatment for hepatitis C virus infection among people who inject drugs.
Treloar C; Hull P; Dore GJ; Grebely J
Drug Alcohol Rev; 2012 Nov; 31(7):918-24. PubMed ID: 22612899
[TBL] [Abstract][Full Text] [Related]
13. Is opioid substitution treatment beneficial if injecting behaviour continues?
Gjersing L; Bretteville-Jensen AL
Drug Alcohol Depend; 2013 Nov; 133(1):121-6. PubMed ID: 23773951
[TBL] [Abstract][Full Text] [Related]
14. Individual versus team-based case-management for clients of opioid treatment services: an initial evaluation of what clients prefer.
Day CA; Demirkol A; Tynan M; Curry K; Hines S; Lintzeris N; Haber PS
Drug Alcohol Rev; 2012 Jun; 31(4):499-506. PubMed ID: 21919976
[TBL] [Abstract][Full Text] [Related]
15. Quality of child health services in primary health care facilities in south-east Nigeria.
Ehiri JE; Oyo-Ita AE; Anyanwu EC; Meremikwu MM; Ikpeme MB
Child Care Health Dev; 2005 Mar; 31(2):181-91. PubMed ID: 15715697
[TBL] [Abstract][Full Text] [Related]
16. Healthcare utilization for somatic conditions among Swedish patients in opioid substitution treatment, with and without on-site primary healthcare.
Vikbladh T; Troberg K; Håkansson A; Dahlman D
BMC Health Serv Res; 2022 Jul; 22(1):971. PubMed ID: 35906595
[TBL] [Abstract][Full Text] [Related]
17. Optimizing primary healthcare experience: assessing client satisfaction in Kaduna State, Northwest Nigeria.
Jibril MB; Sambo MN; Sulaiman H; Musa HS; Musa A; Shuaibu ZB; Aminu L; Wada YH; Ahmed A
BMC Prim Care; 2024 Jun; 25(1):231. PubMed ID: 38926674
[TBL] [Abstract][Full Text] [Related]
18. Dispensing opioid substitution treatment: practices, attitudes and intentions of community-based pharmacists.
Lawrinson P; Roche A; Terao H; Le PP
Drug Alcohol Rev; 2008 Jan; 27(1):47-53. PubMed ID: 18034381
[TBL] [Abstract][Full Text] [Related]
19. 'Not just methadone Tracy': transformations in service-user identity following the introduction of hepatitis C treatment into Australian opiate substitution settings.
Rance J; Treloar C;
Addiction; 2014 Mar; 109(3):452-9. PubMed ID: 24678545
[TBL] [Abstract][Full Text] [Related]
20. A comparative study of opioid substitution therapy utilisation among opioid-dependent men and women.
Gisev N; Degenhardt L; Larney S; Larance B; Gibson A; Kimber J; Burns L
Drug Alcohol Rev; 2014 Sep; 33(5):499-505. PubMed ID: 24840554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
